# Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026
Canonical URL: https://biopharmsignal.com/news/MMSI/merit-medical-systems-to-announce-second-quarter-2026-results-on-july-30-2026-f3864c0a
Ticker: MMSI
Company: Merit Medical
Source: Merit Medical
Published: 2026-07-02 20:05 EST
## Summary

Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced...

## Article Body
Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2026, after the close of the stock market on Thursday, July 30, 2026. Merit plans to hold its investor conference call on the same day (Thursday, July 30, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).

To access the conference call, please pre-register using the following link . Registrants will receive confirmation with dial-in details.

A live webcast and slide deck can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at www.merit.com.

ABOUT MERIT Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,500 people worldwide.
## Recent Company News
- 2026-07-02 20:05 EST — [Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026](https://biopharmsignal.com/news/MMSI/merit-medical-systems-to-announce-second-quarter-2026-results-on-july-30-2026-f3864c0a) — Source: Merit Medical
- 2026-05-19 13:15 EST — [Merit Medical Shareholders Elect Scott R. Ward to Board of Directors](https://biopharmsignal.com/news/MMSI/merit-medical-shareholders-elect-scott-r-ward-to-board-of-directors-b8f2f33a) — Source: Merit Medical
- 2026-05-08 13:25 EST — [Merit Medical to Participate in the Bank of America Healthcare Conference](https://biopharmsignal.com/news/MMSI/merit-medical-to-participate-in-the-bank-of-america-healthcare-conference-20d54d66) — Source: Merit Medical
- 2026-04-30 20:05 EST — [Merit Medical Reports First Quarter 2026 Results and Updates Full-Year Guidance](https://biopharmsignal.com/news/MMSI/merit-medical-reports-first-quarter-2026-results-and-updates-full-year-guidance-651680cc) — Source: Merit Medical
- 2026-04-02 22:00 EST — [Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026](https://biopharmsignal.com/news/MMSI/merit-medical-systems-to-announce-first-quarter-2026-results-on-april-30-2026-1af622dd) — Source: Merit Medical
## Related News
- 2026-07-28 20:15 EST — BDX — [BD Board Declares Dividend](https://biopharmsignal.com/news/BDX/bd-board-declares-dividend-ea66eb4a)
- 2026-07-28 13:00 EST — ENLV — [Enlivex Announces $400,000,000 Private Placement](https://biopharmsignal.com/news/ENLV/enlivex-announces-400-000-000-private-placement-20e71a7a)
- 2026-07-28 12:30 EST — XRAY — [Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship](https://biopharmsignal.com/news/XRAY/dentsply-sirona-advances-commercial-growth-strategy-in-canada-through-expanded-m-e2440bb2)
- 2026-07-28 12:30 EST — RLMD — [Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-uro-oncology-leader-bipin-dalmia-as-chief-business-5c4d7b11)
- 2026-07-28 12:05 EST — RIGL — [Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/RIGL/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2026-financ-5b987d7a)